A phase I study to determine the effect of tamoxifen on the pharmacokinetics of a single 250 mg oral dose of gefitinib (IRESSA) in healthy male volunteers Mireille V. CantariniMerran P. MacphersonChristopher J. Bailey Original Article 23 July 2005 Pages: 557 - 562
Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer Pierpaolo CorrealeFabio FulfaroGuido Francini Original Article 23 July 2005 Pages: 563 - 568
Enhancing the therapeutic responsiveness of photodynamic therapy with the antiangiogenic agents SU5416 and SU6668 in murine nasopharyngeal carcinoma models Qingyu ZhouMalini OlivoBalram Chowbay Original Article 07 July 2005 Pages: 569 - 577
The absolute bioavailability of oral vinorelbine in patients with solid tumors Richard M. LushJeannine S. McCuneDaniel M. Sullivan Original Article 07 July 2005 Pages: 578 - 584
Signal transduction through substance P receptor in human glioblastoma cells: roles for Src and PKCδ Keisuke YamaguchiMark D. RichardsonMadan M. Kwatra Original Article 13 July 2005 Pages: 585 - 593
Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis Z. Nikolic-TomasevicS. JelicZ. Tomasevic Original Article 26 July 2005 Pages: 594 - 602
Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous Vasopressin in non-resectable pancreas cancer M. ÖmanS. LundqvistP. Naredi Original Article 27 July 2005 Pages: 603 - 609
The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel Naoki AgataHiroko NogiDonald Kufe Original Article 10 June 2005 Pages: 610 - 614
Micromolar taxol, with or without hyperthermia, induces mitotic catastrophe and cell necrosis in HeLa cells John MichalakisSpyros D. GeorgatosPanayiotis A. Theodoropoulos Original Article 16 July 2005 Pages: 615 - 622
A phase I trial of celecoxib in combination with docetaxel and irinotecan in patients with advanced cancer Grace K. DySumithra MandrekarAlex A. Adjei Original Article 06 July 2005 Pages: 623 - 628
Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice Christopher L. MortonLisa IaconoPhilip M. Potter Original Article 26 May 2005 Pages: 629 - 636
Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance Elizabeth R. GlazeAmy L. LambertJoseph E. Tomaszewski Original Article 29 June 2005 Pages: 637 - 647
Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients Seiichirou HoshinoYuuichi YamashitaTakayuki Shirakusa Original Article 16 June 2005 Pages: 648 - 652
Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase i study Athanasios AthanasiadisGeorge RoussosGeorge P. Stathopoulos Original Article 04 June 2005 Pages: 653 - 658
Methylene blue is more toxic to erythroleukemic cells than to normal peripheral blood mononuclear cells: a possible use in chemotherapy C. KirszbergV. M. RumjanekM. A. M. Capella Original Article 29 July 2005 Pages: 659 - 665